Phosphorylation of the ribosomal protein S6, a marker of mTOR (mammalian target of rapamycin) pathway activation, is strongly increased in hypertrophic scars and keloids

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|5|1415-1417

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.5, 2015-05, pp. : 1415-1417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy

By  

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 44, Iss. 1, 2018-02 ,pp. : 6-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1199-1207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian target of rapamycin (mTOR) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 376-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian target of rapamycin (mTOR)‐related non‐infectious pneumonitis: a potential biomarker of clinical benefit?

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 350-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

The mTOR Pathway in Breast Cancer

By Hynes Nancy   Boulay Anne  

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 53-61

Springer Publishing Company

Access to resources Recommend Favorite